Taro Pharmaceutical Industries Ltd (NYSE:TARO)

37.72
Delayed Data
As of Sep 27
 -0.08 / -0.21%
Today’s Change
22.89
Today|||52-Week Range
42.22
+29.89%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.4B

Company Description

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Contact Information

Taro Pharmaceutical Industries Ltd.
14 Hakitor Street
Haifa Bay Haifa 2624761
P:(724) 847-5700
Investor Relations:

Employees

Shareholders

Other institutional7.42%
Mutual fund holders6.02%
Individual stakeholders12.06%

Top Executives

Uday Vijaykumar BaldotaChief Executive Officer & Director
William J. CooteChief Financial & Accounting Officer
Hagai ReingoldVice President & Head-Operations
Avi AvramoffVice President & Head-Research & Development
Richard GlazeVice President & Head-Information Technology